Drug approvals

Supriya Lifescience gains ANVISA nod for Esketamine Hydrochloride & files patent for Atorvastatin development

Read more

Zydus receives final approval from the USFDA for Darunavir Tablets 600 mg and 800 mg

Read more

Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline

Read more

Centre clarifies reasons for delay in approvals for remdesivir

Read more

ANDA approvals in 2019: Trends for the generics industry

Read more